Literature DB >> 10777034

The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.

K Higashiura1, N Ura, T Takada, Y Li, T Torii, N Togashi, M Takada, H Takizawa, K Shimamoto.   

Abstract

The aim of this study was to compare the effects of an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II receptor (AT) antagonist on insulin resistance, especially on muscle fiber composition in fructose-induced insulin-resistant and hypertensive rats. Six-week-old male Sprague-Dawley rats were fed either normal rat chow (control) or a fructose-rich diet (FFR). For the last two weeks of a six-week period of either diet, the rats were treated with gum arabic solution as a vehicle (control or FFR), angiotensin-converting enzyme inhibitor (FFR+ACE), temocapril (1 mg/kg/ day) or an angiotensin II receptor antagonist (FFR+AT), CS-866 (0.3 mg/kg/day), by gavage, and then the euglycemic hyperinsulinemic glucose clamp technique was performed to evaluate insulin sensitivity. At the end of the glucose clamp, the soleus muscle was dissected for determination of the muscle fiber composition by ATPase methods. Blood pressure at the glucose clamp in the FFR group was significantly higher than that of the control group, and both temocapril and CS-866 significantly lowered the blood pressure of the FFR group. The average rate of glucose infusion during the glucose clamp, as a measure of insulin sensitivity (M value), was significantly lower in the FFR rats compared to the controls (15.4 +/- 0.4, 10.9 +/- 0.6 mg/kg/min, for control and FFR, respectively, P < .01). Both temocapril and CS-866 partially improved the M values compared to FFR (13.2 +/- 0.7, 12.8 +/- 0.5 mg/kg/min, for FFR+ACE, FFR+AT, respectively, P < .01 compared with FFR, P < .05 compared with control). The composite ratio of type I fibers of the soleus muscle was decreased significantly in the FFR rats compared with the controls (82% +/- 2%, 75% +/- 2%, for control and FFR, respectively, P < .01), and both temocapril and CS-866 restored a composite ratio of type I fibers to the same level as that of the controls (81% +/- 1%, 80% +/- 1% for FFR+ACE and FFR+AT, respectively). The M value was significantly correlated with the composition of type I and type II fibers. These results suggest that the fiber composition of skeletal muscle is correlated to insulin resistance, and that both ACE inhibitors and AT antagonists may modulate the muscle fiber composition in a hypertensive and insulin-resistant animal model, fructose-fed rats, to the same extent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777034     DOI: 10.1016/s0895-7061(99)00174-0

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  14 in total

1.  Role of the renin-angiotensin system in age-related sarcopenia and diastolic dysfunction.

Authors:  Christy S Carter; Leanne Groban
Journal:  Aging health       Date:  2008-02-01

Review 2.  Management of the insulin resistance syndrome.

Authors:  C Desouza; L Gilling; V Fonseca
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

3.  The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients.

Authors:  R Negro; G Formoso; H Hassan
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 4.  Hypertension and insulin disorders.

Authors:  Michinori Imazu
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

5.  Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice.

Authors:  H Makino; M Mukoyama; K Mori; T Suganami; M Kasahara; K Yahata; T Nagae; H Yokoi; K Sawai; Y Ogawa; S Suga; Y Yoshimasa; A Sugawara; I Tanaka; K Nakao
Journal:  Diabetologia       Date:  2006-08-18       Impact factor: 10.122

Review 6.  Vascular signaling pathways in the metabolic syndrome.

Authors:  Hiromi Rakugi; Kei Kamide; Toshio Ogihara
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

7.  The novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function.

Authors:  Yu Wang; Fu-hu Zeng; Chao-liang Long; Zhi-yuan Pan; Wen-yu Cui; Ru-huan Wang; Guo-shu Liu; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2011-11-07       Impact factor: 6.150

8.  Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.

Authors:  Melvin R Hayden; James R Sowers
Journal:  J Am Soc Hypertens       Date:  2008-06-02

Review 9.  The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension.

Authors:  Linda T Tran; Violet G Yuen; John H McNeill
Journal:  Mol Cell Biochem       Date:  2009-06-18       Impact factor: 3.396

10.  Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats.

Authors:  L T Tran; K M MacLeod; J H McNeill
Journal:  Mol Cell Biochem       Date:  2009-01-13       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.